Valiant Organics

Mumbai, India Founded: 2005 • Age: 21 yrs Listed
Manufacturer and supplier of diversified chemicals

About Valiant Organics

Valiant Organics is a publicly listed company based in Mumbai (India) founded in 2005. Manufacturer and supplier of diversified chemicals. The company has 965 employees. Its Indian entity Valiant Organics Limited reported revenue of β‚Ή751 Cr. Valiant Organics offers products and services including Chloro Phenols, Ammonolysis Products, and Acetylation Products. Its focus areas include Chemicals and Materials, Diversified Chemicals and Speciality Chemicals.

Company details

Valiant Organics, established in 2005 and currently in Public stage, focuses on chemicals and materials, diversified chemicals, and speciality chemicals. Manufacturer and supplier of diversified chemicals. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Mumbai, India
  • Employees 965
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website valiantorganics.com
  • Social LinkedIn
  • Legal Name Valiant Organics Limited
Key Metrics
  • Market Cap
    ₹953 Cr

    VALIANTORG · NSE

  • Share Price
    ₹323.15

    -4.98% today

  • Revenue
    ₹739 Cr

    FY 2025-26 · +2.8% YoY

  • EBITDA
    ₹87.06 Cr

    Margin 11.8%

  • Net Profit
    ₹25.98 Cr

    FY 2025-26 · +400.0% YoY

  • P/E (TTM)
    15.5x

    P/B 1.2x

  • ROE
    3.5%

    ROCE 5.4%

  • Debt / Equity
    0.34

    Interest cover 38.3x

  • Employee Count
    965

Products & Services of Valiant Organics

Valiant Organics offers a comprehensive portfolio of products and services, including Chloro Phenols, Ammonolysis Products, and Acetylation Products.

Chloro Phenols
Chemical Manufacturing

Chemicals produced for industrial applications in various sectors

Ammonolysis Products
Chemical Processing

Derived from ammonolysis for use in dyes and pharmaceuticals

Acetylation Products
Chemical Synthesis

Products for cosmetics and polymer industries

Board of directors of Valiant Organics Limited (Valiant Organics)

Valiant Organics Limited is the primary company behind Valiant Organics. The boards of the 2 registered companies of Valiant Organics currently have 11 directors; the longest-serving is Mahek Chheda Manoj, appointed in 2019. 25 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mahek Chheda Manoj
DIN 06763870
Director20 Dec 20196 yrs 11 moValiant Speciality Chemical Limited, Valiant Organics Limited
Kiritkumar Haribhai Desai
DIN 08610595
Director14 Aug 20215 yrs 3 moValiant Organics Limited
Nemin Mahesh Savadia
DIN 00128256
Whole-time director01 May 20224 yrs 6 moValiant Organics Limited
Santosh Shantilal Vora
DIN 07633923
Director01 May 20224 yrs 6 moValiant Organics Limited
Sathiababu Krishnan Kallada
DIN 02107652
Director23 May 20224 yrs 5 moValiant Speciality Chemical Limited, Valiant Organics Limited
Sidhharth Dinesh Shah
DIN 07263018
Whole-time director01 Jun 20224 yrs 5 moValiant Organics Limited
Sonal Amit Vira
DIN 09505883
Director04 Aug 20224 yrs 3 moValiant Organics Limited
Navin Chapshi Shah
DIN 01415556
Director04 Aug 20224 yrs 3 moValiant Organics Limited
Sudhirprakash Baburao Sawant
DIN 02343218
Director19 May 20233 yrs 6 moValiant Organics Limited
Parimal Hasmukhlal Desai
DIN 00009272
Director26 Sep 20242 yrs 1 moValiant Speciality Chemical Limited, Valiant Organics Limited
Paras Sumtichandra Savla
DIN 10773507
Director13 Nov 20242 yrsValiant Organics Limited

People of Valiant Organics

1 people are tracked at Valiant Organics (1 in leadership); the tracked headcount is 965.

NameRoleGroup
Managing DirectorLeadership
Premium access

Complete people profiles for Valiant Organics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Valiant Organics

Valiant Organics is a publicly listed company on the NSE with ticker symbol VALIANTORG in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date14 Oct 2016
  • Listed onBSE: 540145 · NSE: VALIANTORG
  • Listed entityValiant Organics Limited
  • Exchange sectorProcess industries
  • ISININE565V01010
  • Share price₹462.90 (+2.39% on the day) · 2026-10-14
  • Market capitalisation₹1,270 Cr
  • Price to earnings24.0
  • EPS (diluted, trailing year)₹19.30
  • Volume (last session)42,031

Financials of Valiant Organics

Exchange-reported figures of Valiant Organics Limited, the listed company behind Valiant Organics (NSE: VALIANTORG).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹739 Cr
+2.8% YoY
EBITDA
₹87.06 Cr
+63.7% YoY
Profit After Tax
₹25.98 Cr
+400.0% YoY
Net Worth
₹759 Cr
+4.7% YoY
Total Assets
₹1,036 Cr
+5.9% YoY
Total Debt
₹256 Cr
+2.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue7397197231,0521,153755675
Revenue growth+2.8%-0.6%-31.3%-8.8%+52.8%+11.8%-
EBITDA87.0653.1833.26164205205181
EBITDA margin+11.8%+7.4%+4.6%+15.6%+17.8%+27.2%+26.7%
Profit before tax41.932.15(8.70)137176185168
Net profit25.98(8.66)(6.44)84.37113115124
Net profit margin+3.5%-1.2%-0.9%+8.0%+9.8%+15.2%+18.4%
EPS (β‚Ή)11.86(1.33)(3.04)32.4541.7242.19102.00
Balance sheet
Total assets1,0369789901,0151,013718539
Net worth759725729689613502388
Total debt256249257274363209138
Cash & bank2.147.653.808.1545.3830.9812.68
Net working capital203185180243370161105
Cash flow
Cash from operations91.9956.4384.00238(30.75)113161
Cash from investing(86.22)(20.96)(65.19)(143)(124)(156)(184)
Cash from financing(11.07)(31.81)(23.12)(112)16748.6427.16
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue304232218159157204204187
Revenue growth (YoY)+93.4%+13.3%+6.9%-14.8%-1.8%+21.7%--
Other income1.2510.514.627.360.271.700.915.85
EBITDA39.0241.6226.4913.2121.1624.8720.6915.32
EBITDA margin+12.8%+18.0%+12.2%+8.3%+13.5%+12.2%+10.2%+8.2%
Depreciation10.3110.2210.2510.119.789.429.208.99
Interest5.185.133.304.604.216.055.075.83
Profit before tax24.7836.7817.565.867.4411.107.336.35
Tax7.497.511.832.201.762.903.140.89
Net profit17.2929.2715.733.665.688.204.195.46
EPS (β‚Ή)6.1810.445.611.302.022.931.521.01
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue738719677912948574584
Revenue growth+2.7%+6.1%-25.7%-3.9%+65.2%-1.6%-
EBITDA88.2053.9739.54130167157174
EBITDA margin+12.0%+7.5%+5.8%+14.3%+17.6%+27.4%+29.8%
Profit before tax43.072.41(5.13)99.64137152165
Net profit27.17(5.76)(7.58)71.88101115124
Net profit margin+3.7%-0.8%-1.1%+7.9%+10.7%+20.0%+21.2%
EPS (β‚Ή)12.26(1.07)(1.10)27.8337.9142.20102.00
Balance sheet
Total assets936877884887909653505
Net worth697662665666603502388
Total debt219212216220305149117
Cash & bank1.637.433.576.5823.3011.7810.58
Net working capital20213613117725792.7979.47
Cash flow
Cash from operations44.2958.5685.09183(11.17)115160
Cash from investing(38.90)(27.06)(65.03)(90.63)(120)(135)(191)
Cash from financing(11.17)(27.65)(23.12)(109)14621.8935.43
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue304232218159157204204187
Revenue growth (YoY)+93.5%+13.3%+6.8%-14.9%-1.9%+21.7%--
Other income1.112.644.017.360.201.070.675.04
Total expenses265190191143136180183172
EBITDA39.0241.6326.4915.6221.1624.8820.7115.33
EBITDA margin+12.8%+18.0%+12.2%+9.8%+13.5%+12.2%+10.2%+8.2%
Depreciation10.3110.2210.2510.119.789.429.208.99
Interest5.185.133.304.604.216.055.075.83
Profit before tax24.6428.9216.958.277.3710.487.115.55
Tax7.497.091.832.201.762.903.150.91

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 20 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue304232218159157204204187
Revenue growth (YoY)+93.4%+13.3%+6.9%-14.8%-1.8%+21.7%--
Other income1.2510.514.627.360.271.700.915.85
EBITDA39.0241.6226.4913.2121.1624.8720.6915.32
EBITDA margin+12.8%+18.0%+12.2%+8.3%+13.5%+12.2%+10.2%+8.2%
Depreciation10.3110.2210.2510.119.789.429.208.99
Interest5.185.133.304.604.216.055.075.83
Profit before tax24.7836.7817.565.867.4411.107.336.35
Tax7.497.511.832.201.762.903.140.89
Net profit17.2929.2715.733.665.688.204.195.46
EPS (β‚Ή)6.1810.445.611.302.022.931.521.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue7397197231,0521,153755675
Revenue growth+2.8%-0.6%-31.3%-8.8%+52.8%+11.8%-
Other income12.648.789.3012.937.425.946.30
Total expenses652666690888948549494
Employee cost48.8644.9949.3546.3337.1629.4022.78
EBITDA87.0653.1833.26164205205181
EBITDA margin+11.8%+7.4%+4.6%+15.6%+17.8%+27.2%+26.7%
Depreciation39.5735.7634.9229.1929.6221.2415.77
Interest18.2024.0516.3410.796.485.202.57
Profit before tax41.932.15(8.70)137176185168
Tax8.715.58(0.29)34.6148.2653.9942.29
Net profit25.98(8.66)(6.44)84.37113115124
Net profit margin+3.5%-1.2%-0.9%+8.0%+9.8%+15.2%+18.4%
EPS (β‚Ή)11.86(1.33)(3.04)32.4541.7242.19102.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital28.0228.0027.5827.5627.5627.5613.98
Reserves & surplus731697702662586475374
Shareholders' funds (net worth)759725729689613502388
Minority interest(0.01)0.000.0050.8935.756.3013.13
Secured loans185190180219308126105
Unsecured loans71.0458.8676.7754.8955.7982.8133.01
Total debt256249257274363209138
Total liabilities1,0369789901,0151,013718539
Assets
Gross block925847800815656625371
Net block695657643670543510276
Capital work in progress21.1665.7086.1470.8811245.89129
Investments15193.5898.6041.197.816.3422.85
Inventories92.6288.9711412611472.1744.86
Sundry debtors243177209254321157133
Cash & bank balances2.147.653.808.1545.3830.9812.68
Loans & advances15.2582.5681.9844.8542.4038.8529.15
Total current assets353356409434522299219
Total current liabilities151171229191152137115
Net working capital203185180243370161105
Total assets1,0369789901,0151,013718539
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash7.103.447.7525.0512.837.662.86
Net cash from operating activities91.9956.4384.00238(30.75)113161
Net cash from investing activities(86.22)(20.96)(65.19)(143)(124)(156)(184)
Net cash from financing activities(11.07)(31.81)(23.12)(112)16748.6427.16
Net change in cash(5.30)3.66(4.31)(17.30)12.215.184.80
Closing cash2.147.653.808.1545.3830.9812.68
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.8%-0.6%-31.3%-8.8%+52.8%+11.8%-
EBITDA growth+63.7%+59.9%-79.8%-19.8%-0.3%+13.8%-
PBT growth+1850.2%+9998.0%--22.1%-4.7%+9.7%-1.6%
Net income growth+400.0%-34.5%-107.6%-25.5%-1.1%-7.6%-
Revenue CAGR (3Y)-11.1%-14.6%-1.4%+15.9%+18.5%--
EBITDA CAGR (3Y)-19.1%-36.2%-45.5%-3.1%+4.4%--
Profitability & leverage
Net income margin+4.5%-0.5%-1.2%+9.8%+11.1%+17.3%+18.7%
Return on capital employed+5.4%+2.5%+1.1%+15.2%+21.6%+30.7%+39.5%
Return on net worth+3.5%-1.2%-0.9%+15.8%+23.0%+29.5%+39.1%
Debt / equity0.340.350.370.490.510.390.33
Long-term debt / equity0.070.090.100.140.160.180.20
Interest cover38.32138.06-984.347.993.702.821.56
Efficiency & per share
Fixed asset turnover0.830.870.901.431.831.512.25
Inventory turnover8.147.076.018.7712.4112.9014.55
Debtors turnover3.523.723.123.664.835.224.93
EPS (β‚Ή)11.86(1.33)(3.04)32.4541.7242.19102.00
Dividend per share (β‚Ή)0.000.000.001.003.505.0011.00
Book value per share (β‚Ή)271.02258.98264.48253.66225.66184.83317.50
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue304232218159157204204187
Revenue growth (YoY)+93.5%+13.3%+6.8%-14.9%-1.9%+21.7%--
Other income1.112.644.017.360.201.070.675.04
Total expenses265190191143136180183172
EBITDA39.0241.6326.4915.6221.1624.8820.7115.33
EBITDA margin+12.8%+18.0%+12.2%+9.8%+13.5%+12.2%+10.2%+8.2%
Depreciation10.3110.2210.2510.119.789.429.208.99
Interest5.185.133.304.604.216.055.075.83
Profit before tax24.6428.9216.958.277.3710.487.115.55
Tax7.497.091.832.201.762.903.150.91
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue738719677912948574584
Revenue growth+2.7%+6.1%-25.7%-3.9%+65.2%-1.6%-
Other income12.648.258.687.803.3116.905.21
Total expenses650665638782781417410
Employee cost48.8644.9947.5041.8134.0726.6820.49
EBITDA88.2053.9739.54130167157174
EBITDA margin+12.0%+7.5%+5.8%+14.3%+17.6%+27.4%+29.8%
Depreciation39.5735.7633.9727.6327.2918.6313.04
Interest18.2024.0519.3810.546.353.491.29
Profit before tax43.072.41(5.13)99.64137152165
Tax8.715.41(2.09)24.0634.0137.4540.61
Net profit27.17(5.76)(7.58)71.88101115124
Net profit margin+3.7%-0.8%-1.1%+7.9%+10.7%+20.0%+21.2%
EPS (β‚Ή)12.26(1.07)(1.10)27.8337.9142.20102.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital28.0228.0027.5827.5627.5627.5613.98
Reserves & surplus669634637638576475374
Shareholders' funds (net worth)697662665666603502388
Secured loans216211215219270125101
Unsecured loans3.150.320.550.4435.4023.7315.29
Total debt219212216220305149117
Total liabilities936877884887909653505
Assets
Gross block912835788734605558338
Net block683644630610509478256
Capital work in progress21.1665.7086.1470.2011045.89129
Investments63.5454.0854.1752.8053.4941.9733.82
Inventories92.6288.9711411497.3466.0340.93
Sundry debtors243174209212253117111
Cash & bank balances1.637.433.576.5823.3011.7810.58
Loans & advances15.1633.6533.2731.1630.1931.1727.27
Total current assets353304360363404226190
Total current liabilities150168229186147133110
Net working capital20213613117725792.7979.47
Total assets936877884887909653505
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash7.063.216.2622.978.637.552.73
Net cash from operating activities44.2958.5685.09183(11.17)115160
Net cash from investing activities(38.90)(27.06)(65.03)(90.63)(120)(135)(191)
Net cash from financing activities(11.17)(27.65)(23.12)(109)14621.8935.43
Net change in cash(5.78)3.85(3.05)(16.70)14.341.084.82
Closing cash1.637.433.576.5823.3011.7810.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.7%+6.1%-25.7%-3.9%+65.2%-1.6%-
EBITDA growth+63.4%+36.5%-69.6%-22.3%+6.4%-9.4%-
PBT growth+1687.1%+9998.0%--27.3%-9.9%-7.6%-3.7%
Net income growth+571.7%+24.0%-110.6%-29.0%-11.6%-7.5%-
Revenue CAGR (3Y)-6.8%-8.8%+5.7%+16.0%+16.1%+68.2%+99.6%
EBITDA CAGR (3Y)-12.1%-31.4%-36.9%-9.2%-2.1%+81.3%+111.4%
Profitability & leverage
Net income margin+4.7%-0.4%-0.5%+8.3%+10.9%+20.0%+21.2%
Return on capital employed+6.1%+2.9%+1.0%+12.3%+18.3%+26.9%+40.5%
Return on net worth+4.0%-0.9%-1.1%+11.9%+18.6%+25.8%+38.4%
Debt / equity0.320.320.330.410.410.300.26
Long-term debt / equity0.080.090.100.120.150.180.19
Interest cover37.43132.07347.9410.294.542.520.80
Efficiency & per share
Fixed asset turnover0.850.890.891.361.631.282.17
Inventory turnover8.137.075.948.6411.6110.7414.62
Debtors turnover3.543.753.223.925.135.055.04
EPS (β‚Ή)12.26(1.07)(1.10)27.8337.9142.20102.00
Dividend per share (β‚Ή)0.000.000.001.003.505.0011.00
Book value per share (β‚Ή)248.70236.25241.12245.14221.97184.84317.50

Web traffic of Valiant Organics

The website of Valiant Organics (valiantorganics.com) receives about 2K visits a month.

  • Monthly visits
    2K

    ▲ 1% vs previous month

Similar websites

Websites whose visitors overlap most with Valiant Organics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
marketsmojo.com
100%
834.5K#72,195View details

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as Valiant Organics (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 23.86 M
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 515.01 M1,161
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Valiant Organics

VALIANTORG: Q2 CONS NET PROFIT 173M RUPEES VS 56.7M (YOY)
Exchange Update β€’ 15 days ago
VALIANTORG: Q2 REVENUE 3.04B RUPEES VS 1.57B (YOY)
Exchange Update β€’ 15 days ago
VALIANTORG: Q2 EBITDA 390.2M RUPEES VS 212M (YOY); Q2 EBITDA MARGIN 12.83% VS 13.48% (YOY)
Exchange Update β€’ 15 days ago
Premium access

Complete news archive for Valiant Organics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Valiant Organics

Valiant Organics was founded in 2005.

Valiant Organics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Valiant Organics has 965 employees.

The primary company behind Valiant Organics, Valiant Organics Limited, reported revenue of β‚Ή751 Cr for FY 2026, up 3% year on year.

Valiant Organics, established in 2005 and currently in Public stage, focuses on chemicals and materials, diversified chemicals, and speciality chemicals. Manufacturer and supplier of diversified chemicals. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

Valiant Organics offers Chloro Phenols, Ammonolysis Products, and Acetylation Products.

Yes, Valiant Organics is publicly traded on NSE under the ticker symbol VALIANTORG.

Valiant Organics is associated with 2 legal entities: Valiant Organics Limited, Valiant Speciality Chemical Limited.

The legal entities of Valiant Organics currently have 13 directors, including Parimal Hasmukhlal Desai, Sathiababu Krishnan Kallada, Mahek Chheda Manoj and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available